---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-061393"
form_type: "8-K/A"
ticker: "AXGN"
cik: "0000805928"
company_name: "Axogen, Inc."
filed_at: "2026-09-10T20:55:04+00:00"
generated_at: "2026-09-10T20:56:06.986820+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "low"
source: SEC EDGAR
---

# Axogen files merger agreement with BioCircuit Technologies; terms not disclosed

## Summary
- Axogen entered into a merger agreement with BioCircuit Technologies on September 9, 2026, with Omega Merger Sub as merger sub.
- Agreement filed as Exhibit 2.1; Michelle Jarrard named representative for BioCircuit equityholders.
- Corrected investor presentation dated September 10, 2026 furnished as Exhibit 99.2.
- No deal value, premium, or closing conditions disclosed in the filing text.

## SEC filing metadata
- accession: 0001628280-26-061393
- form_type: 8-K/A
- ticker: AXGN
- cik: 0000805928
- company_name: Axogen, Inc.
- filed_at: 2026-09-10T20:55:04+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: low
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/0001628280-26-061393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/805928/000162828026061393/axgn-20260909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-061393
- JSON: https://secwatch.observer/filing/0001628280-26-061393.json
- Plain text: https://secwatch.observer/filing/0001628280-26-061393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.